PHARMA-BIO SERV, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PHARMA-BIO SERV, INC. (PBSV) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$15.55 thousand for the 3-month period ending 2020-04-30, per its 10-Q filed 2020-06-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2020-06-15
- PHARMA-BIO SERV, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-04-30 was -$15.55K, a 102.76% decline year-over-year.
- PHARMA-BIO SERV, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-01-31 was -$11.33K, a 127.36% decline year-over-year.
- PHARMA-BIO SERV, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-07-31 was -$9.40K.
- PHARMA-BIO SERV, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-04-30 was $563.28K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month |
|---|---|---|---|
| 2020-04-30 | -$15.55K 10-Q · filed 2020-06-15 | -$26.87K 10-Q · filed 2020-06-15 | |
| 2020-01-31 | -$11.33K 10-Q · filed 2020-03-16 | ||
| 2019-07-31 | -$9.40K 10-Q · filed 2019-09-16 | $553.88K derived: sum of 2 quarters · filed 2020-06-15 | $595.27K 10-Q · filed 2019-09-16 |
| 2019-04-30 | $563.28K 10-Q · filed 2020-06-15 | $604.67K 10-Q · filed 2020-06-15 | |
| 2019-01-31 | $41.39K 10-Q · filed 2020-03-16 | ||
| 2018-07-31 | $0.00 10-Q · filed 2019-09-16 | -$6.65K derived: sum of 2 quarters · filed 2019-09-16 | -$57.76K 10-Q · filed 2019-09-16 |
| 2018-04-30 | -$6.65K 10-Q · filed 2019-06-14 | -$57.76K 10-Q · filed 2019-06-14 | |
| 2018-01-31 | -$51.12K 10-Q · filed 2019-03-18 |